Literature DB >> 13229240

Metabolic effect of phenylbutazone in gouty and non-gouty arthritis.

E R HUFFMAN, G M WILSON, C J SMYTH, R HILL.   

Abstract

Entities:  

Keywords:  ANALGESICS/therapeutic use; ARTHRITIS/therapy; GOUT/therapy

Mesh:

Substances:

Year:  1954        PMID: 13229240      PMCID: PMC1006757          DOI: 10.1136/ard.13.4.317

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  12 in total

1.  Effects of phenylbutazone in gout.

Authors:  H P JOHNSON; E P ENGLEMAN; P H FORSHAM; M A KRUPP; T W GREEN; A GOLDFIEN
Journal:  N Engl J Med       Date:  1954-04-22       Impact factor: 91.245

2.  Phenylbutazone therapy of arthritis and other painful musculoskeletal disorders.

Authors:  O STEINBROCKER; S BERKOWITZ; M EHRLICH; M ELKIND; S CARP
Journal:  J Am Med Assoc       Date:  1952-11-15

3.  Liver nucleic acid incorporation of phosphorus32 in rats injected with phenylbutazone.

Authors:  N E DELFEL; A C GRIFFIN
Journal:  Stanford Med Bull       Date:  1953-02

4.  Current therapy of gout.

Authors:  C J SMYTH
Journal:  J Am Med Assoc       Date:  1953-07-18

5.  Studies of butazolidin and butapyrin in patients with rheumatic diseases.

Authors:  E C KIDD; K C BOYCE; R H FREYBERG
Journal:  Ann Rheum Dis       Date:  1952-12       Impact factor: 19.103

6.  Phenylbutazone (butazolidin) in rheumatoid arthritis and gout.

Authors:  W C KUZELL; R W SCHAFFARZICK; B BROWN; E A MANKLE
Journal:  J Am Med Assoc       Date:  1952-06-21

7.  Observations on the antirheumatic and physiologic effects of phenylbutazone (butazolidin) and some comparisons with cortisone.

Authors:  B B BRODIE; E W LOWMAN; J J BURNS; P R LEE; T CHENKIN; A GOLDMAN; M WEINER; J M STEELE
Journal:  Am J Med       Date:  1954-02       Impact factor: 4.965

8.  Phenylbutazone (butazolidin) in gout.

Authors:  W C KUZELL; R W SCHAFFARZICK; W E NAUGLER; G GAUDIN; E A MANKLE; B BROWN
Journal:  Am J Med       Date:  1954-02       Impact factor: 4.965

9.  Effect of phenylbutazone (3,5 dioxo-1,2-diphenyl-4-n-butylpyrazolidine) on renal clearance of urate and other discrete renal functions in gouty subjects.

Authors:  T F YU; J H SIROTA; A B GUTMAN
Journal:  J Clin Invest       Date:  1953-11       Impact factor: 14.808

10.  Benefits and toxicity of phenylbutazone (butazolidin) in rheumatoid arthritis.

Authors:  C A L STEPHENS; E E YEOMAN; W P HOLBROOK; D F HILL; W L GOODIN
Journal:  J Am Med Assoc       Date:  1952-11-15
View more
  2 in total

1.  Multiple toxic effects of phenylbutazone; report of a fatal case.

Authors:  T N FRASER
Journal:  Br Med J       Date:  1955-05-28

2.  Gout.

Authors:  R M MASON
Journal:  Postgrad Med J       Date:  1955-12       Impact factor: 2.401

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.